V
Power Law company profile
Verona Pharma
Biotech & Life Sciences · London, United Kingdom · Founded 2005 · IPO 2017 Decacorn
Valuation
$10B
Market cap · 2026
Revenue
$222M
Latest reported FY
Global footprint
Where Verona Pharma has talent and traffic
Web traffic by country
8K
monthly visits
across markets
across markets
🇺🇸 United States58.8%
🇬🇧 United Kingdom13.8%
🇮🇳 India10%
🇪🇸 Spain10%
🇵🇭 Philippines6.3%
Patent intelligence
$68M patent portfolio · 34 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$68M
0.68% of market cap · 2.4× smaller than top peer Amicus Therapeutics ($164M)
34 active patent families
Where Verona Pharma innovates
PharmacologyPyrimidineIsoquinolinePharmaceutical drugPharmaceutical Substances
Above peer median on Strategic
Quality vs same-sector peers
Verona Pharma on the five Patsnap quality dimensions
Verona Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Verona Pharma concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Verona Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Verona Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.